Vulvar cancer epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
| (11 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Vulvar cancer}} | {{Vulvar cancer}} | ||
{{CMG}}{{AE}}{{MD}} | {{CMG}}{{AE}}{{MD}} {{sali}} | ||
==Overview== | ==Overview== | ||
The [[incidence]] of vulvar cancer was estimated to be 2.4 per 100,000 females in the United States. The [[incidence]] of vulvar cancer increases with age; the median age at diagnosis is 68 years. Vulvar cancer is more prevalent in the caucasian race.<ref name=xyz> SEER Stat Fact Sheets: Vulvar Cancer. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015</ref> | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
==Incidence== | ==Incidence== | ||
| Line 10: | Line 11: | ||
==Age== | ==Age== | ||
*The [[incidence]] of vulvar cancer increases with age | *The [[incidence]] of vulvar cancer increases with age; the median age at diagnosis is 68 years.<ref name=xyz> SEER Stat Fact Sheets: Vulvar Cancer. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015</ref> | ||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align=center | {| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align=center | ||
|- | |- | ||
|style="padding: 0 5px; font-size: 100%; background: #4479BA; color: | |style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''Age''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''<20''' ||style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''20-34''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''35-44''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''45-54''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''55-64''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''65-74''' ||style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''75-84''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''>85''' | ||
|- | |- | ||
| style="padding: 0 5px; font-size: 100%; background: #4479BA; color: | | style="padding: 0 5px; font-size: 100%; background: #4479BA; color:F5F5F5 ; width: 10%" align=center |'''Incidence''' | ||
|style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |0.2% | |style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |0.2% | ||
|style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |2% | |style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |2% | ||
| Line 27: | Line 28: | ||
==Race== | ==Race== | ||
* Vulvar cancer is more prevalent in the caucasian.<ref name=xyz> SEER Stat Fact Sheets: Vulvar Cancer. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015</ref> | * Vulvar cancer is more prevalent in the caucasian race.<ref name=xyz> SEER Stat Fact Sheets: Vulvar Cancer. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015</ref> | ||
{| style="border: 0px; font-size: 90%; margin: 3px; width: | {| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align=center | ||
|- | |- | ||
|style="padding: 0 5px; font-size: 100%; background: #4479BA; color: | |style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''Race''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''All Races''' ||style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''White''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''Black''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center | '''Asian/Pacific Islander''' ||style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''American Indian/Alaska Native'''||style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''Hispanic'''||style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''Non-Hispanic''' | ||
|- | |- | ||
| style="padding: 0 5px; font-size: 100%; background: #4479BA; color: | | style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''Incidence'''|| style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |2.4 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |2.6 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |1.8 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |0.9 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |2.0 per 100,000 || style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |1.7 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |2.5 per 100,000 | ||
|} | |} | ||
==References== | ==References== | ||
{{Reflist| | {{Reflist|1}} | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Gynecology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Gynecology]] | [[Category:Gynecology]] | ||
Latest revision as of 19:56, 10 April 2019
|
Vulvar cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Vulvar cancer epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Vulvar cancer epidemiology and demographics |
|
Risk calculators and risk factors for Vulvar cancer epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2] Syed Musadiq Ali M.B.B.S.[3]
Overview
The incidence of vulvar cancer was estimated to be 2.4 per 100,000 females in the United States. The incidence of vulvar cancer increases with age; the median age at diagnosis is 68 years. Vulvar cancer is more prevalent in the caucasian race.[1]
Epidemiology and Demographics
Incidence
The overall age adjusted incidence rate of vulvar cancer among females is approximately 2.4 per 100,000 individuals in the United States.[1]
Age
| Age | <20 | 20-34 | 35-44 | 45-54 | 55-64 | 65-74 | 75-84 | >85 |
| Incidence | 0.2% | 2% | 6.1% | 15.3% | 19.8% | 19.8% | 22.1% | 14.9% |
Race
- Vulvar cancer is more prevalent in the caucasian race.[1]
| Race | All Races | White | Black | Asian/Pacific Islander | American Indian/Alaska Native | Hispanic | Non-Hispanic |
| Incidence | 2.4 per 100,000 | 2.6 per 100,000 | 1.8 per 100,000 | 0.9 per 100,000 | 2.0 per 100,000 | 1.7 per 100,000 | 2.5 per 100,000 |
References
- ↑ 1.0 1.1 1.2 1.3 SEER Stat Fact Sheets: Vulvar Cancer. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015